FCG Investment Company’s GSK GSK Stock Holding History

FCG Investment Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44,626	Closed	-$1.73M	–	101
2025 Q1	$1.73M	Buy	+44,626	New	+$1.63M	1.09%	27

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FCG Investment Company's GSK Position: Q2 2025 in Review

FCG Investment Company sold out of GSK (GSK) in Q2 2025, closing a stake of 44,626 shares — an estimated $1.73M sold.

FCG Investment Company first reported a position in GSK in Q1 2025 and held it in 1 quarter. The position peaked at $1.73M in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

FCG Investment Company reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
FCG Investment Company sold 44,626 GSK shares in Q2 2025, an estimated $1.73M.
FCG Investment Company first reported a position in GSK in Q1 2025 and held it in 1 quarter.
FCG Investment Company's GSK position peaked at $1.73M in Q1 2025.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on FCG Investment Company's 13F filing for Q2 2025, filed 16 Jul 2025.